We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Stent-Grafts Repair Aneurysms

By HospiMedica staff writers
Posted on 27 Feb 2006
Aneurysm of the aorta and dissections, life-threatening conditions that can eventually lead to rupture of the aorta and almost certain death, can now be treated with a minimally invasive procedure, according to a new study. More...


The study examined an experimental procedure called endovascular thoracic aortic repair (ETAR), which repairs and strengthens the aorta by using fabric tubes called stent-grafts to reinforce weak spots. Seventy-three patients, three-quarters of whom were considered too high-risk to have surgery, underwent an ETAR procedure and were monitored for 12 years. Average survival was nearly four years, and almost half of the patients are still alive today and have not needed additional procedures. About 12% of the patients developed "endoleaks,” in which blood entered the bulging area of the aneurysm despite the presence of the stent-graft. Nine of these patients had an additional procedure to fix the problem. The findings were presented at the annual meeting of the Society of Thoracic Surgeons (STS), held in Chicago (IL, USA) during January 2006.

Since aortic aneurysms and dissections tend to form later in life and are aggravated by factors such as high cholesterol, smoking, and family history, some patients are too high-risk and inherently unlikely to be able to withstand open-chest surgery. For patients over the age of 80, and those who have stiffened arteries (atherosclerosis), diabetes, lung problems, and a history of heart disease or high blood pressure, ETAR may be the only option.

"The minimally invasive approach to major aortic problems promises to revolutionize the way a broad spectrum of patients are treated,” said Himanshu Patel, M.D., the lead author of the STS scientific poster and an assistant professor of cardiac surgery at the University of Michigan Medical School (Ann Arbor, USA). "Even in high-risk patients who would not otherwise be treatable, we see acceptable, encouraging results.”

An estimated 3% of adults over age 65 have some form of aortic aneurysm, and more than 15,000 people in the United States alone die each year from ruptured thoracic aortic aneurysms, dissections, and other problems. Tens of thousands of others may have the conditions but not know it, because aortic problems often do not cause symptoms until they rupture.




Related Links:
University of Michigan Medical School

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Pediatric Mask
Respire SOFT
Gold Member
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.